Pacira Pharmaceuticals, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 65250 (Pacira Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
5
Package NDCs
3
Products
3
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| EXPAREL bupivacaine 13.3 mg/mL INJECTION, SUSPENSION, LIPOSOMAL | 65250-0266-04 | — | On market | View → |
| EXPAREL bupivacaine 13.3 mg/mL INJECTION, SUSPENSION, LIPOSOMAL | 65250-0133-04 | — | On market | View → |
| Zilretta triamcinolone acetonide extended-release injectable suspension KIT | 65250-0003-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.